Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients.

{"article_title":"Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients.","author":"Menter A, Cordoro KM, Davis DMR, Kroshinsky D, Paller AS, Armstrong AW, Connor C, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kivelevitch D, Korman NJ, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Parra SL, Pathy AL, Farley Prater EA, Rupani RN, Siegel M, Stoff B, Strober BE, Wong EB, Wu JJ, Hariharan V, Elmets CA","journal_title":"Journal of the American Academy of Dermatology","issn":"1097-6787","isbn":"","publication_date":"2020-01-01","volume":"82","issue":"1","first_page":"161","page_count":"","accession_number":"31703821","doi":"10.1016\/j.jaad.2019.08.049","publisher":"Mosby","doctype":"Duplicate Publication","subjects":"Biological Products therapeutic use; Dermatologic Agents therapeutic use; Methotrexate therapeutic use; Photochemotherapy; Psoriasis drug therapy; Psoriasis epidemiology; Adolescent; Adrenal Cortex Hormones therapeutic use; Anthralin therapeutic use; Calcineurin Inhibitors therapeutic use; Cardiovascular Diseases epidemiology; Child; Child, Preschool; Coal Tar therapeutic use; Comorbidity; Cyclosporine therapeutic use; Dyslipidemias epidemiology; Evidence-Based Medicine; Humans; Infant; Infant, Newborn; Inflammatory Bowel Diseases epidemiology; Insulin Resistance; Mental Health; Metabolic Syndrome epidemiology; Nicotinic Acids therapeutic use; Obesity epidemiology; Psoriasis psychology; Retinoids therapeutic use","interest_area":["Dermatology"," Pediatric Medicine"],"abstract":"Psoriasis is a chronic, multisystem, inflammatory disease that affects approximately 1% of children, with onset most common during adolescence. This guideline addresses important clinical questions that arise in psoriasis management and provides evidence-based recommendations. Attention will be given to pediatric patients with psoriasis, recognizing the unique physiology, pharmacokinetics, and patient-parent-provider interactions of patients younger than 18 years old. The topics reviewed here mirror those discussed in the adult guideline sections, excluding those topics that are irrelevant to, or lack sufficient information for, pediatric patients. Copyright \u00a9 2019 American Academy of Dermatology, Inc. All rights reserved.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=31703821","isPdfLink":false,"isSAML":false,"an":"31703821","number_other":"","type_pub":"","issn_electronic":"1097-6787","languages":"English","language":"eng","date_entry":"Date Created: 20191110 Date Completed: 20200629 Latest Revision: 20200629","date_update":"20240105","titleSource":"Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2020 Jan; Vol. 82 (1), pp. 161-201. Date of Electronic Publication: 2019 Nov 05.","date_pub_cy":"","type_document":"","contract_publisher":"","authored_on":"2020-01-01","description":"Psoriasis is a chronic, multisystem, inflammatory disease that affects approximately 1% of children, with onset most common during adolescence. This guideline addresses important clinical questions that arise in psoriasis management and provides evidence-based recommendations. Attention will be given to pediatric patients with psoriasis, recognizing the unique physiology, pharmacokinetics, and patient-parent-provider interactions of patients younger than 18 years old. The topics reviewed here mirror those discussed in the adult guideline sections, excluding those topics that are irrelevant to, or lack sufficient information for, pediatric patients.<br \/> (Copyright © 2019 American Academy of Dermatology, Inc. All rights reserved.)","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&scope=site&db=mdl&AN=31703821&authtype=shib&custid=ns346513&group=main&profile=eds","no_of_pages":"","authored_by":"Menter A, Cordoro KM, Davis DMR, Kroshinsky D, Paller AS, Armstrong AW, Connor C, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kivelevitch D, Korman NJ, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Parra SL, Pathy AL, Farley Prater EA, Rupani RN, Siegel M, Stoff B, Strober BE, Wong EB, Wu JJ, Hariharan V, Elmets CA"}